Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

IKT Financial Statements and Analysis

NASDAQ : IKT

Inhibikase Therapeutics, Inc.

$2.60
0.25+10.64%
At Close 4:00 PM
66.25
BESG ScoreESG Rating

IKT FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

IKT Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue0001.0079.569K
cost of revenue06.569K6.568K6.568K6.568K
gross profit0-6.569K-6.568K-6.567K73.001K
gross profit ratio000-6.567K0.917
research and development expenses4.19M3.076M2.751M3.003M3.226M
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses1.638M1.975M2.025M1.394M1.623M
other expenses00000
operating expenses5.827M5.051M4.776M4.397M4.769M
cost and expenses5.827M5.051M4.782M4.404M4.769M
interest income49.41K90.927K132.725K225.626K173.677K
interest expense00000
depreciation and amortization6.568K6.569K6.568K6.568K6.583K
ebitda-5.821M-5.044M-4.776M-4.397M-4.762M
ebitda ratio000-4.397M-59.851
operating income-5.827M-5.051M-4.782M-4.404M-4.769M
operating income ratio000-4.404M-59.934
total other income expenses net49.41K90.927K132.725K225.629K173.677K
income before tax-5.778M-4.96M-4.65M-4.178M-4.595M
income before tax ratio000-4.178M-57.751
income tax expense002.001.000
net income-5.778M-4.96M-4.65M-4.178M-4.595M
net income ratio000-4.178M-57.751
eps-0.65-0.66-0.73-0.68-0.86
eps diluted-0.65-0.66-0.73-0.68-0.86
weighted average shs out8.883M7.536M6.341M6.186M5.342M
weighted average shs out dil8.883M7.536M6.341M6.186M5.342M
Graph

IKT Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents913.42K3.086M2.353M9.165M14.861M
short term investments2.33M4.854M7.396M4.087M1.97M
cash and short term investments3.244M7.94M9.749M13.252M16.832M
net receivables00000
inventory00000
other current assets946.457K662.787K1.058M958.996K371.538K
total current assets4.19M8.603M10.808M14.211M17.551M
property plant equipment net186.772K223.997K260.264K295.599K330.03K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets000-1.000
total non current assets186.772K223.997K260.264K295.598K330.03K
other assets0001.000
total assets4.377M8.827M11.068M14.507M17.881M
account payables2.529M1.341M1.294M646.767K734.561K
short term debt145.21K304.448K151.159K531.879K149.03K
tax payables00000
deferred revenue00000
other current liabilities2.233M2.06M2.788M2.26M1.858M
total current liabilities4.907M3.705M4.233M3.439M2.742M
long term debt025.606K58.33K90.124K121.013K
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities025.606K58.329K90.124K121.013K
other liabilities001.0000
capital lease obligations145.21K177.83K58.33K90.124K270.043K
total liabilities4.907M3.73M4.291M3.529M2.863M
preferred stock00000
common stock7.464K7.216K6.477K6.186K5.361K
retained earnings-82.288M-76.51M-71.55M-66.901M-62.723M
accumulated other comprehensive income loss1.754K-1.024K-1.80K877.00-143.00
other total stockholders equity81.748M81.60M78.322M77.872M77.735M
total stockholders equity-530.591K5.097M6.777M10.978M15.018M
total equity-530.591K5.097M6.777M10.978M15.018M
total liabilities and stockholders equity4.377M8.827M11.068M14.507M17.881M
minority interest00000
total investments2.33M4.854M7.396M4.087M1.97M
total debt145.21K177.83K209.489K622.003K270.043K
net debt-768.21K-2.909M-2.144M-8.543M-14.591M
Graph

IKT Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-223.179K0-663.268K
stock based compensation30.697K53.434K122.249K129.781K124.845K
change in working capital-132.032K722.615K592.436K336.462K928.528K
accounts receivables00079.602K-15.083K
inventory000249.443K0
accounts payables396.434K479.267K-87.794K-19.585K-204.932K
other working capital-528.466K243.348K680.23K27.002K1.149M
other non cash items-352.599K-412.697K237.435K17.28K663.268K
net cash provided by operating activities-5.054M-3.867M-3.442M-4.105M-4.565M
investments in property plant and equipment4.00000-14.238K
acquisitions net000014.238K
purchases of investments-776.974K-8.433M-8.797M-1.948M2.93M
sales maturities of investments3.32M5.121M6.681M19.009M-365.655K
other investing activites2.543M-3.312M00-14.238K
net cash used for investing activites2.543M-3.312M-2.116M17.061M2.55M
debt repayment00000
common stock issued3.244M366.999K-138.104K70.00-35.986K
common stock repurchased0000-35.986K
dividends paid00000
other financing activites30.608K-30.608K0035.986K
net cash used provided by financing activities3.244M366.999K-138.104K70.00-35.986K
effect of forex changes on cash00000
net change in cash733.109K-6.812M-5.696M12.956M-2.051M
cash at end of period3.086M2.353M9.165M14.861M1.905M
cash at beginning of period2.353M9.165M14.861M1.905M3.957M
operating cashflow-5.054M-3.867M-3.442M-4.105M-4.565M
capital expenditure4.00000-14.238K
free cash flow-5.054M-3.867M-3.442M-4.105M-4.58M
Graph

Frequently Asked Questions

How did Inhibikase Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, IKT generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Inhibikase Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Inhibikase Therapeutics, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.

Have IKT's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. IKT incurred $5.83M worth of Operating Expenses, while it generated -$5.83M worth of Operating Income.

How much Net Income has IKT posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Inhibikase Therapeutics, Inc., the company generated -$5.78M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Inhibikase Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Inhibikase Therapeutics, Inc. as of the end of the last quarter was $913.42K.

What are IKT's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, IKT had Total Net Receivables of $0.00.

In terms of Total Assets and Current Assets, where did Inhibikase Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of IKT were $4.19M, while the Total Assets stand at $4.38M.

As of the last quarter, how much Total Debt did Inhibikase Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of IKT's debt was $145.21K at the end of the last quarter.

What were IKT's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, IKT reported total liabilities of $4.91M.

How much did IKT's Working Capital change over the last quarter?

Working Capital Change for IKT was -$132.03K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

IKT generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. IKT generated -$5.05M of Cash from Operating Activities during its recently reported quarter.

What was IKT's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. IKT reported a $733.11K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph